The critique discusses 58 peptides in various clinical phases, indicating a sturdy pipeline of peptide therapies concentrating on PPIs. In this way, peptide-primarily based drug development might be major to the future of focused cure.4 These studies reveal the likely application of food items-derived peptides concentrating on RAAS for the pr